speb/financial-data huggingface dataset:
IQV cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
IQV income_statement (annual, 2024-12-31) — Selling General And Administration: 1992000000.00
IQV balance_sheet (annual, 2024-12-31) — Share Issued: 258200000.00
IQV income_statement (annual, 2024-12-31) — Special Income Charges: -67000000.00
IQV cash_flow (annual, 2024-12-31) — Stock Based Compensation: 206000000.00
IQV balance_sheet (annual, 2024-12-31) — Stockholders Equity: 6067000000.00
IQV balance_sheet (annual, 2024-12-31) — Tangible Book Value: -13142000000.00
IQV income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -12060000.00
IQV income_statement (annual, 2024-12-31) — Tax Provision: 301000000.00
IQV income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.18
IQV balance_sheet (annual, 2024-12-31) — Taxes Receivable: 36000000.00
IQV balance_sheet (annual, 2024-12-31) — Total Assets: 26899000000.00
IQV balance_sheet (annual, 2024-12-31) — Total Capitalization: 18905000000.00
IQV balance_sheet (annual, 2024-12-31) — Total Debt: 14156000000.00
IQV balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 6067000000.00
IQV income_statement (annual, 2024-12-31) — Total Expenses: 13136000000.00
IQV balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 20832000000.00
IQV balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 21070000000.00
IQV balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 13875000000.00
IQV income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 2202000000.00
IQV balance_sheet (annual, 2024-12-31) — Total Tax Payable: 156000000.00
IQV income_statement (annual, 2024-12-31) — Total Unusual Items: -67000000.00
IQV income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -67000000.00
IQV balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 82100000.00
IQV balance_sheet (annual, 2024-12-31) — Treasury Stock: 10103000000.00
IQV balance_sheet (annual, 2024-12-31) — Working Capital: -1128000000.00
IQV income_statement (quarterly, 2025-03-31) — +Operating Expense: 773000000.00
IQV income_statement (quarterly, 2025-03-31) — +Total Revenue: 3829000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3559000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1409000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 11170000000.00
IQV income_statement (quarterly, 2025-03-31) — Basic Average Shares: 175700000.00
IQV income_statement (quarterly, 2025-03-31) — Basic EPS: 1.42
IQV cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1702000000.00
IQV cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -142000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 177000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Capital Stock: 3000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1740000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1876000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1740000000.00
IQV cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -258000000.00
IQV cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -305000000.00
IQV cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 568000000.00
IQV cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -124000000.00
IQV cash_flow (quarterly, 2025-03-31) — Change In Receivables: 128000000.00
IQV cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 4000000.00
IQV cash_flow (quarterly, 2025-03-31) — Changes In Cash: 5000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Common Stock: 3000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5977000000.00
IQV cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -375000000.00
IQV income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2531000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Current Assets: 5911000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Current Debt: 1222000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1222000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1940000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1940000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 7179000000.00
IQV cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -41000000.00
IQV cash_flow (quarterly, 2025-03-31) — Deferred Tax: -41000000.00
IQV cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 265000000.00
IQV income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 265000000.00
IQV cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 265000000.00
IQV income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 265000000.00
IQV income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 177400000.00
IQV income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.40
IQV income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 249000000.00
IQV income_statement (quarterly, 2025-03-31) — EBIT: 488000000.00
IQV income_statement (quarterly, 2025-03-31) — EBITDA: 753000000.00
IQV income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest Net Of Tax: -13000000.00
IQV cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 13000000.00
IQV cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 33000000.00
IQV cash_flow (quarterly, 2025-03-31) — End Cash Position: 1740000000.00
IQV cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -258000000.00
IQV cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 426000000.00
IQV cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 1000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -978000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Goodwill: 15027000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 19530000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Gross PPE: 768000000.00
IQV income_statement (quarterly, 2025-03-31) — Gross Profit: 1298000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 139000000.00
IQV income_statement (quarterly, 2025-03-31) — Interest Expense: 165000000.00
IQV income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 165000000.00
IQV income_statement (quarterly, 2025-03-31) — Interest Income: 11000000.00
IQV income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 11000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Invested Capital: 20307000000.00
IQV cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -305000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 130000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 383000000.00
IQV cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 2260000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 177000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 13108000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13285000000.00
IQV cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 2260000000.00
IQV cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -2096000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 253000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Minority Interest: 8000000.00
IQV income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
IQV cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -147000000.00
IQV cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -375000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Net Debt: 12590000000.00
IQV income_statement (quarterly, 2025-03-31) — Net Income: 249000000.00
IQV income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 249000000.00
IQV income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 249000000.00
IQV income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 249000000.00
IQV income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 249000000.00
IQV cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 249000000.00
IQV income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 249000000.00
IQV income_statement (quarterly, 2025-03-31) — Net Interest Income: -154000000.00
IQV cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -17000000.00
IQV cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 164000000.00
IQV cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 164000000.00
IQV income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -154000000.00
IQV cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -12000000.00
IQV cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Net PPE: 768000000.00
IQV cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -142000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -13553000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 245000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 197000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 245000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 197000000.00
IQV income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 786000000.00
IQV income_statement (quarterly, 2025-03-31) — Normalized Income: 275763000.00
IQV cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 568000000.00
IQV cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 14000000.00
IQV income_statement (quarterly, 2025-03-31) — Operating Income: 525000000.00
IQV income_statement (quarterly, 2025-03-31) — Operating Revenue: 3829000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 174100000.00
IQV balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 558000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 319000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -978000000.00
IQV income_statement (quarterly, 2025-03-31) — Other Income Expense: -48000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 4503000000.00
IQV cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 5000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 485000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 676000000.00
IQV income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -15000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Other Properties: 768000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1896000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 136000000.00
IQV income_statement (quarterly, 2025-03-31) — Other Special Charges: 4000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Payables: 3698000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3698000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 166000000.00
IQV income_statement (quarterly, 2025-03-31) — Pretax Income: 323000000.00
IQV cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -35000000.00
IQV cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -147000000.00
IQV cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -19000000.00
IQV cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -142000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Receivables: 3311000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -37000000.00
IQV income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2531000000.00
IQV income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 265000000.00
IQV cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -2096000000.00
IQV cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -375000000.00
IQV income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 29000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 6314000000.00
IQV cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 2000000.00
IQV income_statement (quarterly, 2025-03-31) — Selling General And Administration: 508000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Share Issued: 258500000.00
IQV income_statement (quarterly, 2025-03-31) — Special Income Charges: -33000000.00
IQV cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 72000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5977000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -13553000000.00
IQV income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -6237000.00
IQV income_statement (quarterly, 2025-03-31) — Tax Provision: 61000000.00
IQV income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.19
IQV balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 43000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Total Assets: 27322000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 19085000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Total Debt: 14507000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5985000000.00
IQV income_statement (quarterly, 2025-03-31) — Total Expenses: 3304000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 21337000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 21411000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 14158000000.00
IQV income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 496000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 139000000.00
IQV income_statement (quarterly, 2025-03-31) — Total Unusual Items: -33000000.00
IQV income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -33000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 84400000.00
IQV balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 10532000000.00
IQV balance_sheet (quarterly, 2025-03-31) — Working Capital: -1268000000.00
IQV income_statement (quarterly, 2025-06-30) — +Operating Expense: 785000000.00
IQV income_statement (quarterly, 2025-06-30) — +Total Revenue: 4017000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3399000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1485000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 11222000000.00
IQV income_statement (quarterly, 2025-06-30) — Basic Average Shares: 171800000.00
IQV income_statement (quarterly, 2025-06-30) — Basic EPS: 1.55
IQV cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1740000000.00
IQV cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -151000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 210000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Capital Stock: 3000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2039000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2188000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Cash Financial: 2039000000.00
IQV cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 145000000.00
IQV cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -346000000.00
IQV cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 443000000.00
IQV cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -245000000.00
IQV cash_flow (quarterly, 2025-06-30) — Change In Receivables: 141000000.00
IQV cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -104000000.00
IQV cash_flow (quarterly, 2025-06-30) — Changes In Cash: 242000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Common Stock: 3000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 5778000000.00
IQV cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -657000000.00
IQV income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2694000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Current Assets: 6345000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Current Debt: 1313000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1313000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 2123000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 2123000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 7572000000.00
IQV cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -45000000.00
IQV cash_flow (quarterly, 2025-06-30) — Deferred Tax: -45000000.00
IQV cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 276000000.00
IQV income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 276000000.00
IQV cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 276000000.00
IQV income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 276000000.00
IQV income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 173200000.00
IQV income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.54
IQV income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 266000000.00
IQV income_statement (quarterly, 2025-06-30) — EBIT: 505000000.00
IQV income_statement (quarterly, 2025-06-30) — EBITDA: 781000000.00
IQV income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: -1000000.00
IQV cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 1000000.00
IQV cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 57000000.00
IQV cash_flow (quarterly, 2025-06-30) — End Cash Position: 2039000000.00
IQV cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 145000000.00
IQV cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 292000000.00
IQV cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -17000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -882000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Goodwill: 15611000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 20207000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Gross PPE: 816000000.00
IQV income_statement (quarterly, 2025-06-30) — Gross Profit: 1323000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 124000000.00
IQV income_statement (quarterly, 2025-06-30) — Interest Expense: 182000000.00
IQV income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 182000000.00
IQV income_statement (quarterly, 2025-06-30) — Interest Income: 10000000.00
IQV income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 10000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Invested Capital: 21268000000.00
IQV cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -346000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 134000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 406000000.00
IQV cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 2600000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 210000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 14177000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 14387000000.00
IQV cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 2600000000.00
IQV cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1744000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 272000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Minority Interest: 8000000.00
IQV cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -195000000.00
IQV cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -657000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Net Debt: 13451000000.00
IQV income_statement (quarterly, 2025-06-30) — Net Income: 266000000.00
IQV income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 266000000.00
IQV income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 266000000.00
IQV income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 266000000.00
IQV income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 266000000.00
IQV cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 266000000.00
IQV income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 266000000.00
IQV income_statement (quarterly, 2025-06-30) — Net Interest Income: -172000000.00
IQV cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
IQV cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 856000000.00
IQV cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 856000000.00
IQV income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -172000000.00
IQV cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -54000000.00
IQV cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 0.00
IQV balance_sheet (quarterly, 2025-06-30) — Net PPE: 816000000.00
IQV cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -151000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -14429000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 345000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 216000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 345000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 216000000.00
IQV income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 813000000.00
IQV income_statement (quarterly, 2025-06-30) — Normalized Income: 292464000.00
IQV cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 443000000.00
IQV cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -16000000.00
IQV income_statement (quarterly, 2025-06-30) — Operating Income: 538000000.00
IQV income_statement (quarterly, 2025-06-30) — Operating Revenue: 4017000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 170000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 551000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 613000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -882000000.00
IQV income_statement (quarterly, 2025-06-30) — Other Income Expense: -43000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 4596000000.00
IQV cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 6000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 513000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 671000000.00
IQV income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -11000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Other Properties: 816000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1896000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 149000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Payables: 3523000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 3523000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 200000000.00
IQV income_statement (quarterly, 2025-06-30) — Pretax Income: 323000000.00
IQV cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
IQV cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -195000000.00
IQV cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
IQV cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -151000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Receivables: 3406000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -37000000.00
IQV income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2694000000.00
IQV income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 276000000.00
IQV cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1744000000.00
IQV cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -657000000.00
IQV income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 32000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 6580000000.00
IQV cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
IQV income_statement (quarterly, 2025-06-30) — Selling General And Administration: 509000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Share Issued: 258500000.00
IQV income_statement (quarterly, 2025-06-30) — Special Income Charges: -32000000.00
IQV cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 60000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 5778000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -14429000000.00
IQV income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -5536000.00
IQV income_statement (quarterly, 2025-06-30) — Tax Provision: 56000000.00
IQV income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.17
IQV balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 62000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Total Assets: 28632000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 19955000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Total Debt: 15700000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 5786000000.00
IQV income_statement (quarterly, 2025-06-30) — Total Expenses: 3479000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 22846000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 22287000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 15274000000.00
IQV income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 506000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 124000000.00
IQV income_statement (quarterly, 2025-06-30) — Total Unusual Items: -32000000.00
IQV income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -32000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 88500000.00
IQV balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 11145000000.00
IQV balance_sheet (quarterly, 2025-06-30) — Working Capital: -1227000000.00
IQV income_statement (quarterly, 2025-09-30) — +Operating Expense: 800000000.00
IQV income_statement (quarterly, 2025-09-30) — +Total Revenue: 4100000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3550000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1423000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 11318000000.00
IQV income_statement (quarterly, 2025-09-30) — Basic Average Shares: 170200000.00
IQV income_statement (quarterly, 2025-09-30) — Basic EPS: 1.94
IQV cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2039000000.00
IQV cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -136000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 233000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Capital Stock: 3000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1814000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1972000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Cash Financial: 1814000000.00
IQV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -572000000.00
IQV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -550000000.00
IQV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 908000000.00
IQV cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 106000000.00
IQV cash_flow (quarterly, 2025-09-30) — Change In Receivables: 173000000.00
IQV cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 279000000.00
IQV cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 173000000.00
IQV cash_flow (quarterly, 2025-09-30) — Changes In Cash: -214000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Common Stock: 3000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6160000000.00
IQV cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
IQV income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2727000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Current Assets: 5979000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Current Debt: 2164000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2164000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 2160000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 2160000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 8508000000.00
IQV cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -46000000.00
IQV cash_flow (quarterly, 2025-09-30) — Deferred Tax: -46000000.00
IQV cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 286000000.00
IQV income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 286000000.00
IQV cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 286000000.00
IQV income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 286000000.00
IQV income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 171700000.00
IQV income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.93
IQV income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 331000000.00
IQV income_statement (quarterly, 2025-09-30) — EBIT: 597000000.00
IQV income_statement (quarterly, 2025-09-30) — EBITDA: 883000000.00
IQV income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest Net Of Tax: 0.00
IQV cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 0.00
IQV cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -11000000.00
IQV cash_flow (quarterly, 2025-09-30) — End Cash Position: 1814000000.00
IQV cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -572000000.00
IQV cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 772000000.00
IQV cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -4000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -928000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Goodwill: 15948000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 20655000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Gross PPE: 824000000.00
IQV income_statement (quarterly, 2025-09-30) — Gross Profit: 1373000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 119000000.00
IQV income_statement (quarterly, 2025-09-30) — Interest Expense: 189000000.00
IQV income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 189000000.00
IQV income_statement (quarterly, 2025-09-30) — Interest Income: 13000000.00
IQV income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 13000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Invested Capital: 21117000000.00
IQV cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -550000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 130000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 405000000.00
IQV cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 500000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 233000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 12793000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 13026000000.00
IQV cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 500000000.00
IQV cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1036000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 275000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Minority Interest: 128000000.00
IQV income_statement (quarterly, 2025-09-30) — Minority Interests: -1000000.00
IQV cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -484000000.00
IQV cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
IQV balance_sheet (quarterly, 2025-09-30) — Net Debt: 13143000000.00
IQV income_statement (quarterly, 2025-09-30) — Net Income: 331000000.00
IQV income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 331000000.00
IQV income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 332000000.00
IQV income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 331000000.00
IQV income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 331000000.00
IQV cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 332000000.00
IQV income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 332000000.00
IQV income_statement (quarterly, 2025-09-30) — Net Interest Income: -176000000.00
IQV cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -1000000.00
IQV cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -536000000.00
IQV cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -536000000.00
IQV income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -176000000.00
IQV cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -5000000.00
IQV cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -4000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Net PPE: 824000000.00
IQV cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -61000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -14495000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 390000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 207000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 390000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 207000000.00
IQV income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 903000000.00
IQV income_statement (quarterly, 2025-09-30) — Normalized Income: 347280000.00
IQV cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 908000000.00
IQV cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -4000000.00
IQV income_statement (quarterly, 2025-09-30) — Operating Income: 573000000.00
IQV income_statement (quarterly, 2025-09-30) — Operating Revenue: 4100000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 170300000.00
IQV balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 516000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 515000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -928000000.00
IQV income_statement (quarterly, 2025-09-30) — Other Income Expense: 11000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 4707000000.00
IQV cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 6000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 474000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 698000000.00
IQV income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 31000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Other Properties: 824000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1891000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 158000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Payables: 3669000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3669000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 177000000.00
IQV income_statement (quarterly, 2025-09-30) — Pretax Income: 408000000.00
IQV cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: -31000000.00
IQV cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -484000000.00
IQV cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -1000000.00
IQV cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -136000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Receivables: 3314000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -45000000.00
IQV income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2727000000.00
IQV income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 286000000.00
IQV cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1036000000.00
IQV cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
IQV income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 20000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 6911000000.00
IQV cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
IQV cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 75000000.00
IQV income_statement (quarterly, 2025-09-30) — Selling General And Administration: 514000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Share Issued: 258800000.00
IQV income_statement (quarterly, 2025-09-30) — Special Income Charges: -20000000.00
IQV cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 55000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6160000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -14495000000.00
IQV income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -3720000.00
IQV income_statement (quarterly, 2025-09-30) — Tax Provision: 76000000.00
IQV income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.19
IQV balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 45000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Total Assets: 28727000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 18953000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Total Debt: 15190000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 6288000000.00
IQV income_statement (quarterly, 2025-09-30) — Total Expenses: 3527000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 22439000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 22748000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 13931000000.00
IQV income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 553000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 119000000.00
IQV income_statement (quarterly, 2025-09-30) — Total Unusual Items: -20000000.00
IQV income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -20000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 88500000.00
IQV balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 11144000000.00
IQV balance_sheet (quarterly, 2025-09-30) — Working Capital: -2529000000.00
IQV income_statement (annual, 2025-12-31) — +Operating Expense: 3143000000.00
IQV income_statement (quarterly, 2025-12-31) — +Operating Expense: 785000000.00
IQV income_statement (annual, 2025-12-31) — +Total Revenue: 16310000000.00
IQV income_statement (quarterly, 2025-12-31) — +Total Revenue: 4364000000.00
IQV balance_sheet (annual, 2025-12-31) — Accounts Payable: 780000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 780000000.00
IQV balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1668000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1668000000.00
IQV balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -905000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -905000000.00
IQV balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 11375000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 11375000000.00
IQV cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 984000000.00
IQV cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 984000000.00
IQV income_statement (annual, 2025-12-31) — Basic Average Shares: 171900000.00
IQV income_statement (quarterly, 2025-12-31) — Basic Average Shares: 170000000.00
IQV income_statement (annual, 2025-12-31) — Basic EPS: 7.91
IQV income_statement (quarterly, 2025-12-31) — Basic EPS: 3.02
IQV cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1702000000.00
IQV cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1814000000.00
IQV cash_flow (annual, 2025-12-31) — Capital Expenditure: -603000000.00
IQV cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -174000000.00
IQV balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 225000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 225000000.00
IQV balance_sheet (annual, 2025-12-31) — Capital Stock: 3000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Capital Stock: 3000000.00
IQV balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1980000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1980000000.00
IQV balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2141000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2141000000.00
IQV balance_sheet (annual, 2025-12-31) — Cash Financial: 1980000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Cash Financial: 1980000000.00
IQV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -150000000.00
IQV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 535000000.00
IQV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2305000000.00
IQV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1104000000.00
IQV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2654000000.00
IQV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 735000000.00
IQV cash_flow (annual, 2025-12-31) — Change In Account Payable: -96000000.00
IQV cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -299000000.00
IQV cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 242000000.00
IQV cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 505000000.00
IQV cash_flow (annual, 2025-12-31) — Change In Payable: -395000000.00
IQV cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -395000000.00
IQV cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 218000000.00
IQV cash_flow (annual, 2025-12-31) — Change In Receivables: 60000000.00
IQV cash_flow (quarterly, 2025-12-31) — Change In Receivables: -382000000.00
IQV cash_flow (annual, 2025-12-31) — Change In Tax Payable: -299000000.00
IQV cash_flow (annual, 2025-12-31) — Change In Working Capital: 125000000.00
IQV cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -54000000.00
IQV cash_flow (annual, 2025-12-31) — Changes In Cash: 199000000.00
IQV cash_flow (quarterly, 2025-12-31) — Changes In Cash: 166000000.00
IQV balance_sheet (annual, 2025-12-31) — Common Stock: 3000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Common Stock: 3000000.00
IQV balance_sheet (annual, 2025-12-31) — Common Stock Equity: 6503000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 6503000000.00
IQV cash_flow (annual, 2025-12-31) — Common Stock Payments: -1244000000.00
IQV cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -212000000.00
IQV income_statement (annual, 2025-12-31) — Cost Of Revenue: 10880000000.00
IQV income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2928000000.00
IQV balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2070000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2070000000.00
IQV balance_sheet (annual, 2025-12-31) — Current Assets: 6249000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Current Assets: 6249000000.00
IQV balance_sheet (annual, 2025-12-31) — Current Debt: 1840000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Current Debt: 1840000000.00
IQV balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1840000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1840000000.00
IQV balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 2118000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 2118000000.00
IQV balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 2118000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 2118000000.00
IQV balance_sheet (annual, 2025-12-31) — Current Liabilities: 8338000000.00
IQV balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 8338000000.00
IQV cash_flow (annual, 2025-12-31) — Deferred Income Tax: -180000000.00
IQV cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -48000000.00
IQV cash_flow (annual, 2025-12-31) — Deferred Tax: -180000000.00
IQV cash_flow (quarterly, 2025-12-31) — Deferred Tax: -48000000.00
IQV cash_flow (annual, 2025-12-31) — Depreciation: 160000000.00
IQV cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1144000000.00
IQV cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 317000000.00
IQV income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1144000000.00
IQV income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 317000000.00
IQV cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1144000000.00
IQV cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 317000000.00
IQV income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 1144000000.00
IQV income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 317000000.00
IQV income_statement (annual, 2025-12-31) — Diluted Average Shares: 173500000.00
IQV income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 171900000.00
IQV income_statement (annual, 2025-12-31) — Diluted EPS: 7.84
IQV income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.99
IQV income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1360000000.00
IQV income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 514000000.00
IQV income_statement (annual, 2025-12-31) — EBIT: 2320000000.00
IQV income_statement (quarterly, 2025-12-31) — EBIT: 730000000.00
IQV income_statement (annual, 2025-12-31) — EBITDA: 3464000000.00
IQV income_statement (quarterly, 2025-12-31) — EBITDA: 1047000000.00